NCT01404572 Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01400451 Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) Status TERMINATED Phase PHASE1
NCT01394666 Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Status COMPLETED Phase N/A
NCT01393964 Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function Status COMPLETED Phase PHASE1
NCT01392703 Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations Status COMPLETED Phase PHASE1
NCT01392677 Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea Status COMPLETED Phase PHASE3
NCT01389323 BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C Status COMPLETED Phase PHASE3
NCT01389310 Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe Status COMPLETED Phase N/A
NCT01386359 Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant Status COMPLETED Phase N/A
NCT01379287 Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01377935 Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments Status COMPLETED Phase N/A
NCT01377389 Ipilimumab + Androgen Depravation Therapy in Prostate Cancer Status TERMINATED Phase PHASE2
NCT01369095 Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression Status COMPLETED Phase PHASE2
NCT01368783 Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers Status UNKNOWN Phase PHASE1
NCT01367275 Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF Status TERMINATED Phase PHASE2
NCT01363817 Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Status COMPLETED Phase PHASE1
NCT01361555 Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression Status TERMINATED Phase PHASE2
NCT01359657 Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1